Stay Up-to-Date with our Monthly OrthoFuture Newsletter

Exclusive U.S. Market Analysis on ACL/PCL Reconstruction Devices

The knee is the most susceptible joint in the human body to pressure and injury. Knees undergo complex interactions of rotational and extensional movements. The U.S. market for ACL/PCL reconstruction devices indicates growth at a single-digit CAGR over the forecast period to exceed $359 million by 2026. What are the ACL and PCL? ACL and

Hammertoe Devices and Implants: Top Brands in the U.S. Market

  Hammertoe is a toe deformity where one or both of the joints, excluding the big toe, are bent abnormally due to a contracture. This places pressure on the toe when the feet are shoed. This may create foot corns around or between the toes and calluses, which are usually found on the ball of

Key Factors Limiting Europe’s Intramedullary Nail Market

Europe’s market for intramedullary nails experienced a substantial decline in 2020, following COVID-19 and restrictions associated with social distancing. Unfortunately, the market has yet to recover and indicates clear signs of a decrease into 2026 to reach €97.8 million. WHAT ARE INTRAMEDULLARY NAILS? Intramedullary nails (IM nails) are solid or cannulated metal rods typically used

$3.5 Billion Dollars: How the U.S. Orthopedic Biomaterials Market is Growing

What segments are in the U.S. Orthopedic Biomaterials market? The U.S. orthopedic biomaterials market includes bone graft substitutes, growth factors, cellular allografts, cell therapies, hyaluronic acid viscosupplementation, and cartilage repair. Bone graft substitutes fill bone voids or act as extenders to eliminate the need for autograft harvesting. Growth factors are naturally occurring proteins within the

Top 5 Interbody Device Companies in the United States

Overview In the United States alone, there are over 50 interbody device companies all competing for market share. But who really are the top competitors within this growing market and how are they succeeding above the rest? Despite COVID-19 headwinds, the interbody device market is prosperous as many companies have grown significantly and are experiencing

Top Ankle Replacement Implants in the United States

  Many ankle replacement implant manufacturers in the United States are looking to increase their share of this growing market. Ankle replacement is one of the fastest-growing segments in the foot and ankle devices manufacturing industry, showing growth rates close to 10%. Under this scenario, there has been a lot of activity in the industry,

3 Simple Ways to Stay on Top of the Volatile Market in 2021

Keeping up with the market is hard enough without a looming global pandemic swinging it out of control. Although it is difficult to stay on top of recent trends, it is essential if you want to stay ahead of the market and your competition. Continually tracking trends, identifying who is doing well and why, along

FDA Clears Catalyst OrthoScience Reverse Shoulder System

Catalyst OrthoScience Inc., a medical device company focused on the upper extremity orthopedics market, has received clearance from the U.S. Food & Drug Administration (FDA) to market its reverse shoulder system. Catalyst’s reverse shoulder system is a single-tray arthroplasty system that is made to combine beneficial and evidence-based attributes of reverse shoulder arthroplasty design. The

Top Orthopedic Companies in the United States

Did you know there are over 8.9 million orthopedic procedures performed in the United States each year, with the orthopedic biomaterials market showing the greatest forecast growth? As this market continues to grow and innovative technologies are being designed, we have compiled a list of the top companies within different categories of the orthopedics market including:  Orthopedic

Are Genetically Engineered Cells the Future of Osteoarthritis Treatment?

The growing elderly demographic has been a considerable market driver within the orthopedic biomaterials market, the incidence of osteoarthritis and other forms of degenerative diseases have also been on the rise. In an effort to find a cure for such diseases researchers have been investigating the abilities of smart biomaterials.  Smart biomaterials autonomously respond to

Zimmer Biomet Trauma Implants Cleared the CE Mark, but will an FDA Approval Follow?

Zimmer Biomet’s Bactiguard-coated orthopedic trauma implants have recently received European regulatory clearance and CE mark. Preparations for registering the implants in the U.S. market are also ongoing. The Bactiguard technology was originally developed by the Swedish medical device company, which goes by the same name. The company focuses on developing solutions that reduce the risk

DePuy Synthes Receives 510(k) FDA Clearance for VELYS™ Robotic-Assisted Solution

DePuy Synthes has recently announced they received 510(k) FDA Clearance for VELYS, a robotic-assisted system designed for use with the Attune total knee system. DePuy Synthes has described the Velys platform as a first-of-its-kind, table-mounted solution with an efficient design capable of integrating into any operating room. The company said it adapts to a surgeon’s

Breakthrough FDA Approval for ACL Tears to be Healed Instead of Being Rebuilt

The U.S. Food and Drug Administration recently granted marketing authorization for an anterior cruciate ligament (ACL) implant, intended to perform as an alternative to traditional ACL reconstructions. The Bridge-Enhanced ACL Repair (BEAR) Implant, by Miach Orthopaedics, differs from the traditional surgical reconstruction as it does not require the use of harvested tendons for ACL repair

Medtronic’s MIS Drill Received FDA Approval Ahead Of Schedule

Medtronic has announced that the U.S. Food and Drug Administration (FDA) has cleared the use of navigated interbody high-speed drills with the Robotic Guidance System. Even in the midst of the COVID19 pandemic the company has received the clearance earlier than anticipated. This system now integrates the surgical planning software with robotic guidance. Spinal instruments

Stryker Goes to Extrem(iti)es with Wright Medical Acquisition

Stryker has announced it has cleared all regulatory hurdles previously in the way of its planned $4.7 billion acquisition of Wright Medical. The tender offer was initiated back in November 2019 and has now been completed as of November 11, 2020.  “Wright Medical has built a successful business, and together we look forward to working

Anika Announces New Wrist Replacement Technology – WristMotion System

Anika Therapeutics, Inc. announced that the WristMotion Total Arthroplasty System received 510(k) clearance from the U.S. Food and Drug Administration. The WristMotion System is used in procedures to replace painful wrist joints due to rheumatoid arthritis, osteoarthritis, or post-traumatic arthritis, allowing a patient to maintain native biomechanics. This replacement implant is an entirely new approach

World Spine Day 2020 – BACK ON TRACK

October 16th is the official World Spine Day, organized and coordinated by the World Federation of Chiropractors. This year’s theme is Back On Track, celebrating people being able to reactivate and revitalize their bodies by getting out and focusing on effective spine care. World Spine Day is celebrated to raise awareness around the prevention and

Radical Market Share Shifts due to Smith+Nephew’s Acquisition of Integra LifeSciences’ Extremity Orthopedics Division

Smith+Nephew (LSE:SN, NYSE:SNN) have announced that they have an agreement to acquire the Extremity Orthopedics business of Integra LifeSciences Holdings Corporation (NASDAQ:IART) for $240 million.  Smith+Nephew noted that the portfolio includes devices, implants and instruments designed for shoulder replacement and reconstruction of bones in the hand, wrist and elbow, as well as the foot and

Engage Surgical Granted FDA Approval for Cementless Engage Partial Knee System

Engage Surgical has gained FDA approval for its Engage Partial Knee system, making it the only cementless partial knee system approved for use in the U.S. It uses Engage’s innovative Anchor technology to provide stability at the tibial surface, and increased compression compared to other techniques. The Engage Partial Knee system is also combined with

Osso VR Partnering with MicroPort Orthopedics to Provide VR Training Module for Hip and Knee System

Osso VR has been providing a virtual surgical training platform to provide an education to medical students who are currently unable to receive in-person training due to COVID-19. They have recently partnered with MicroPort Orthopedics, to provide students with an opportunity to take part in VR training of the surgical techniques used by MicroPort. The

Top 6 Surprising Developments in the U.S. Sports Medicine Device Market

According to the latest study by iData Research, the U.S. sports medicine market was valued at $1.7 billion by 2020. The total market is highly limited by the relatively stable incidence rate of tendon and ligament injuries, which varies greatly among different anatomies and different population groups. In spite of this trend, the level of

Anika Releasing Six New FDA-Approved Sports Medicine Products in 2020

Anika, an orthopedic device manufacturer based out of Bedford, Massachusetts, has announced the release of six new sports medicine products in 2020. This marks the first time Anika has released new products since acquiring Parcus Medical and Arthrosurface earlier in the year. All six of these products have received FDA approval. They are mainly focused

Over 1 Million Hernia Repair Surgeries are Performed in the US – Market Overview

Based on the latest market study by iData Research, there are over 1 million hernia repair surgeries performed every year in the United States. A hernia is a condition in which part of the intestine bulges through a weak area in the abdominal muscles, so hernia repair involves repositioning this intestine back into the body

Vivex Publishes Initial Clinical Results of VIA Disc Injectable Treatment

Vivex is a company based out of Atlanta, Georgia, that specializes in regenerative medicine. Vivex has developed the VIA Disc, an innovative injectable treatment for degenerative disc disease. The first major clinical study regarding this treatment was conducted recently, with promising results. Lower back pain is the leading cause of work disability in the world

Sirakoss Ltd. granted 510(k) FDA clearance for Osteo3 ZP Putty

The FDA has granted 510(k) clearance for the Osteo3 ZP Putty from Sirakoss Ltd. Sirakoss is based out of Aberdeen, Scotland, and originated from research conducted out of the University of Aberdeen. Sirakoss produces nanosynthetic bone regeneration products, providing an alternative to other devices used in spine and trauma bone grafts. Products such as these

Moving Forward in the Spine Surgery Industry – COVID-19 Impacts

From the onset of COVID-19, changes were made to various facets of healthcare systems, including the Spine Surgery industry. Many of these changes were adopted in a reactionary manner, in order to protect those at risk. However, it has become evident that some of these changes bear issues that must be addressed to ensure optimal

First Augmented Reality Spinal Surgery Completed in U.S. with Augmedics XVision Spine System

Augmedics, a company based out of Chicago, gained FDA approval for the sale of its XVision Spine System in the U.S. in December 2019. Now, this technology has been used for its first spine surgery in the U.S. Using the patient’s CT scan data, the XVision Spine System provides a 3-dimensional visualization of the patient’s

Zebra Medical Vision Granted FDA Approval for AI Vertebral Fracture Detector

Zebra Medical Vision, based in Israel, has recently been granted FDA 510(k) approval for its artificial intelligence product that detects vertebral compression fractures. There currently exists a major problem with under-detection and under-reporting of vertebral compression fractures. Zebra Medical Vision states that a large proportion of these fractures remain unreported or missed. This can have

Nevro Corp. Gains CE Mark for Spinal Cord Stimulation Device

Existing research suggests that SCS generally provides positive outcomes for patients. A recent literature review funded by Nevro Corp. found that 10kHz SCS, in particular, was effective in treating chronic back and leg pain. Of the studies included in this literature review, 60-80% of patient respondents reported that their pain was relieved by ≥ 50%

CMS Recommends Reopening Healthcare in Areas of Low COVID-19 Cases

The Center for Medicare and Medicaid Services (CMS) is reissuing new guidelines for states and regions seeing declining and stabilizing COVID-19 infection rates and recommending healthcare facilities in these areas to resume providing elective procedures to patients without COVID-19 symptoms. On March 18, 2020, the CMS announced they would postponing non-essential medical and surgical procedures

iData ResearchOrthoFuture